Sleep drug studied for breast cancer Survivors' insomnia
NCT ID NCT06162663
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 24 times
Summary
This study tested whether the sleep medication suvorexant (20 mg) could help breast cancer survivors who have trouble sleeping. Participants were postmenopausal women currently taking hormone therapy. The trial compared suvorexant to a placebo, with both groups also learning about good sleep habits. The study was stopped early after enrolling only 5 people, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
MUSC Department of Family Medicine
Charleston, South Carolina, 29425, United States
Conditions
Explore the condition pages connected to this study.